Tracked deals
62
62 tracked deals across 2026.
Tracked deals
62
62 tracked deals across 2026.
Buyer mix
Strategic-led
47 strategic · 19 pe
Top trend
Volume peaked in 2021
223 tracked deals announced in 2021.
Buyer Snapshot
Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.
| Buyer | # Deals | Focus | Type |
|---|---|---|---|
| Johnson & Johnson | 2 | Multinational healthcare company with expanding cardiovas... | Strategic |
| ALR Technologies | 1 | Diabetes management company developing the ALRT Diabetes ... | Mixed |
| AMETEK, Inc. | 1 | Industrial technology provider with advanced analytical, ... | Strategic |
| AP Technologies | 1 | Singapore-headquartered contract manufacturer focused on ... | Strategic |
| ARCHIMED | 1 | Healthcare‑focused investment firm and strategic financia... | PE |
| Advanced Sterilization Products (ASP) | 1 | Fortive’s infection-prevention business that designs and ... | Strategic |
| Ally Bridge Group | 1 | Global healthcare-focused investment firm investing acros... | PE |
| Altivera Medical Holdings, LLC | 1 | Healthcare company positioning to operate pain management... | Mixed |
| American Industrial Partners (AIP) | 1 | Operationally oriented industrials investor that makes co... | PE |
| Apollo Global Management (funds managed by) | 1 | Alternative investment manager making private capital inv... | PE |
Last 10 years
Supporting Data
Gainline Capital Partners’ portfolio company, M&M International, has acquired KC Tech, a medical-device-focused manufacturer and strategic partner. The deal expands M&M’s manufacturing capabilities and broadens its product portfolio by adding KC Tech’s larger-diameter tubing line. Financial terms were not disclosed.
ALR Technologies entered into a letter of intent to acquire 100% of CGM Medical Technology Singapore and to acquire certain assets of CGM Medical Technology Shenzhen. The deal values CGM Medical Singapore at a total purchase consideration including 200 million ordinary shares and $45 million, with additional contingent earn-out payments tied to free cash flow. ALR Technologies plans to use the acquired technology and licenses to build a manufacturing facility in the Johor-Singapore Special Economic Zone and expects to sign definitive agreements by late July 2026 (Singapore) and late August 2026 (Shenzhen).
InMode said its board received an unsolicited proposal from M.N. Business Strategy to acquire all outstanding ordinary shares not already owned by M.N. Business Strategy and its affiliates. The proposed merger would value the shares at $16.20 per share in cash, and InMode has formed a special committee of independent directors to evaluate the offer.
Advanced Sterilization Products (ASP), part of Fortive’s Infection Prevention group, acquired a majority share of UV Smart, a European leader in UV-C high level disinfection technology. The acquisition is intended to expand ASP’s infection-prevention clinical solutions portfolio and accelerate global adoption of UV Smart’s disinfection products across Europe and North America.
HR HealthCare announced the acquisition of SteriGear, LLC, including the Fig Leaf brand of urinary drainage devices and SteriGear’s portfolio of covers and drapes. The deal is intended to strengthen HR HealthCare’s bladder management/urology platform across the care continuum (acute care, post-acute, long-term care, skilled nursing, and home-based care).
CVC Catalyst III has agreed to acquire a majority stake in WillowWood Holdings Inc., partnering as the majority investor alongside Blue Sea Capital, the Arbogast family, and management, who will reinvest. The transaction is expected to close in the third quarter of 2026, subject to regulatory approvals.
Spectrum Vascular, backed by SK Capital Partners, has acquired Piccolo Medical, a developer of 510(k)-cleared catheter guidance products. The deal is intended to integrate Piccolo’s real-time catheter navigation technology with Spectrum’s vascular access portfolio to accelerate commercialization and establish a new standard of care.
Galmed Pharmaceuticals entered into a definitive agreement to acquire Colospan, a commercial-stage medical device company focused on reducing anastomotic leak complications in colorectal surgery via its CG-100 intraluminal bypass device. Following a restructuring of acquisition terms, Galmed consummated the acquisition, and Colospan became a wholly owned subsidiary.
Novanta Inc. entered into a definitive agreement to acquire Riverpoint Medical from Arlington Capital Partners for $1.2 billion upfront cash plus a $250 million milestone payment in Q1 2027, for total value up to $1.45 billion. The deal is expected to close in Q3 2026, subject to customary regulatory approvals and closing conditions.
Lineus Medical, developer of the SafeBreak Vascular breakaway IV device, completed a strategic recapitalization with KMF Investments. The transaction, finalized at the start of 2026, establishes KMF as a stable financial backer and provides resources to accelerate SafeBreak Vascular adoption and growth in the United States.
ResMed completed its acquisition of Noctrix Health, a medical device company developing wearable therapeutics for chronic neurological disorders. The deal expands ResMed’s clinical sleep health portfolio with Noctrix’s Nidra Tonic Motor Activation (TOMAC) therapy for moderate-to-severe Restless Legs Syndrome (RLS), with Noctrix becoming a wholly owned subsidiary. The acquisition was previously announced as a definitive merger agreement to acquire Noctrix for $340 million, expected to close on or around June 1, 2026.
Johnson & Johnson acquired Atraverse Medical, strengthening its J&J MedTech cardiac electrophysiology portfolio. The acquisition follows the May 15, 2026 close and is referenced in connection with medtech founder John Slump’s subsequent launch of Metis MedTech.
Olympus signed a definitive agreement to acquire BioProtect for $270 million to expand its urology and oncology technology portfolio for prostate cancer care. The deal is expected to close by the end of Q2 2026, subject to customary closing conditions, with portions of the purchase price held in escrow tied to uninterrupted operation.
AP Technologies announced the acquisition of Blueacre Technology, a Dundalk, Ireland-based specialist in laser micromachining and nitinol processing for the medical device industry. The deal expands AP Technologies’ vertically integrated catheter platform by adding nitinol and precision laser processing capabilities and establishes AP Technologies’ first European operation in Ireland.
Atreon Orthopedics and RenovoDerm have merged to form Atreon Orthopedics, Inc., combining synthetic biomaterial technologies for tissue repair and remodeling. The combined company aims to scale its Autobiologic platform technology across orthopedic, trauma, sports medicine, reconstructive, foot and ankle, and complex wound applications.
Endologix, a privately held medical device company, announced it will acquire the Pounce Thrombectomy System from Surmodics. The FDA-cleared, fully mechanical peripheral thrombectomy platform is intended to complement Endologix’s existing vascular intervention portfolio and expand the continuum of care for patients with peripheral vascular disease.
Everis Medical, a Kalamazoo, Michigan-based medical device company focused on otolaryngology and airway management, announced the acquisition of Hood Laboratories. The deal expands Everis’ portfolio of ENT, airway, and thoracic devices and establishes a meaningful entry into airway management.
BellaMia Technologies and Dominion Aesthetic Technologies completed a strategic merger valued at $200 million, combining their laser and robotic medical aesthetics technologies. The merged company will operate under the BellaMia Technologies name with Janet Campbell as CEO, aiming to expand commercial reach and accelerate product development across body contouring and skin rejuvenation.
Artivion, Inc. has completed the acquisition of Endospan Ltd., following U.S. FDA PMA approval of the NEXUS Aortic Arch System. The deal includes a $135 million upfront net purchase price (plus purchase price adjustments/offsets for previously provided loans) and potential additional consideration up to $200 million tied to U.S. commercial performance over the next two years.
Charlesbank-backed Tecomet and Nordic-backed Orchid Orthopedic Solutions have completed their merger to create a scaled global manufacturing platform serving medical device customers. The combination brings together manufacturing capabilities across orthopedic and related medtech end markets.
Drummond Scientific Company announced it has acquired Accu-Glass, LLC, a St. Louis-based manufacturer of high-precision glass capillaries used in medical and diagnostic applications. Accu-Glass will operate as a wholly owned subsidiary with employees retained and operations continuing at its current facility.
vVARDIS Holding AG announced a strategic minority investment from funds managed by Apollo Global Management to support the company’s global expansion. The funding is intended to accelerate the commercial rollout of vVARDIS’ non-invasive Curodont peptide-based dental treatment, with a focus on scaling adoption across the United States and Europe.
Johnson & Johnson entered into a definitive agreement to acquire Atraverse Medical, a privately held medtech company developing the HOTWIRE Transseptal Access System for left-heart access during cardiac electrophysiology procedures. The deal is expected to close in Q2 2026, subject to customary closing conditions, with financial terms not disclosed.
Bioretec Oy disclosed managers’ transaction activity indicating that Stephen Industries Inc Oy, a closely associated party of board member Kustaa Poutiainen, subscribed for shares outside a trading venue. The transaction details were reported with an aggregated share volume and very low nominal prices per unit.
Medtronic plc has completed its acquisition of CathWorks, a privately held medical device company focused on transforming how coronary artery disease is diagnosed and treated. The deal is valued at $585 million, with potential undisclosed earn-out payments, and enhances Medtronic’s interventional cardiology portfolio via the CathWorks FFRangio System.
Stereotaxis entered into a definitive agreement to acquire Robocath, a venture-backed developer of robotic technologies for interventional cardiology and neurointerventions. The deal is expected to close in mid-2026, with consideration including a $20 million upfront payment and up to $25 million in contingent payments tied to regulatory and commercial milestones.
Avanos Medical has entered into a definitive agreement to be acquired by affiliates of American Industrial Partners (AIP) in an all-cash transaction valued at approximately $1.272 billion. Avanos stockholders will receive $25.00 per share, representing a premium of about 72.1% to the April 13, 2026 closing price, and the deal is expected to close in the second half of 2026 subject to customary approvals and regulatory clearances.
Bioness Medical, Inc. announced the acquisition of the PoNS (Portable Neuromodulation Stimulator) System product line. The deal expands Bioness’s neurorehabilitation platform from functional electrical stimulation (FES) into non-invasive central neuromodulation delivered via the tongue, supporting multi-modal treatment for patients with gait and balance disorders.
Avista Healthcare Partners acquired Bentec Medical, a Woodland, California manufacturer of complex silicone-based medical device components and finished goods. The deal was announced April 8, 2026, and financial terms were not disclosed.
A Neumann & Associates, LLC announced the closing of the sale of a medical device manufacturer in the Philadelphia metro region in a transaction valued at $6 million. The company described the target as a medical device manufacturer with machining capabilities, significant operating margins, and nationwide/international sales, and noted a transition period under the new owner.
Merit Medical Systems acquired View Point Medical, Inc. in a transaction valued at approximately $140 million to expand its therapeutic oncology portfolio. Under the terms of the deal, Merit will pay $90 million in cash at closing plus two additional $25 million payments due on the first and second anniversaries, and View Point will become a wholly owned subsidiary of Merit.
Zynex, Inc. has been acquired by Altivera Medical Holdings, LLC in a deal approved by the U.S. Bankruptcy Court for the Southern District of Texas. The acquisition follows Zynex’s Chapter 11 restructuring and resolution of pending government investigations.
Thrombolex, Inc., a commercial-stage medical device company focused on pharmaco-mechanical lysis for thromboembolic diseases, announced the closing of a $50 million Series A equity financing led by OrbiMed. The funding is intended to expand U.S. commercialization and advance clinical evidence generation for its FDA-cleared BASHIR Endovascular Catheter (BEC) platform for pulmonary embolism and other VTE indications.
Mechanix Wear, backed by Gryphon Investors, acquired OTEX, a developer and manufacturer of tech-enabled personal protective equipment (PPE) featuring patented safety and air-quality/cooling technologies. OTEX CEO Jake Weidert will remain with the organization as Vice President of Technology and Materials, and OTEX will operate under Mechanix Wear’s Chicago Protective Apparel division; transaction terms were not disclosed.
H&T Presspart, a division of the Heitkamp Thumann Group, acquired a majority stake in Plas-Tech Engineering. The transaction closed in November 2025 and expands H&T Presspart’s manufacturing footprint into the United States by adding Plas-Tech’s medical device manufacturing site in Lake Geneva, Wisconsin.
Quantum Surgical has acquired NeuWave Medical and combined both businesses under a newly created parent, Precision IO Group Inc., to expand a robotic-assisted tumor ablation platform. The deal is supported by investment from Ally Bridge Group and aims to integrate Quantum Surgical's Epione robotic system with NeuWave's microwave ablation technology to broaden access to minimally invasive interventional oncology care.
Zavation Medical Products, a portfolio company of Gemspring Capital, acquired ChoiceSpine Holdings, a Knoxville, Tennessee designer and manufacturer of spinal implant systems. ChoiceSpine will maintain its brand and operations as the companies work toward a unified organization; terms were not disclosed.
Tactile Systems Technology (doing business as Tactile Medical) acquired LymphaTech, Inc. for an upfront cash payment of $6.8 million plus potential milestone-based consideration to expand its lymphedema solutions into digital and connected care. LymphaTech co-founders joined Tactile to support commercial adoption and R&D as Tactile integrates the company’s 3D measurement and monitoring platform into its portfolio.
Natus Sensory has acquired TheraB Medical, a medical technology company focused on neonatal jaundice treatment using wearable phototherapy. The deal expands Natus Sensory’s newborn care portfolio with SnugLit, a FDA-cleared swaddle-style phototherapy system designed to support family-centered care while delivering continuous therapy.
UNIMED, a ZCG Private Equity–backed provider of medical and compliance solutions for the maritime industry, has acquired Regenboog Shipping Pharmacy, a Rotterdam-based distributor of pharmaceutical products and medical devices serving the maritime sector. The add-on expands Unimed’s presence in the Netherlands, builds on its recent Lagaay integration, and brings Regenboog’s portfolio of more than 1,000 SKUs and ~300+ customers into the Unimed platform.
AMETEK has acquired LKC Technologies, a maker of portable, non-invasive ophthalmic diagnostic devices used to test and monitor eye health. The deal is intended to expand AMETEK’s ophthalmic product portfolio and broaden its presence in eye care diagnostics.
Arctic Vision (Cayman) Limited has entered into an agreement to acquire the innovative ophthalmic device business of MDCO Technology. The deal will make MDCO’s premium intraocular lens, implantable contact lens (phakic lens), and refractive-device platforms a wholly owned subsidiary within Arctic Vision’s global ophthalmic innovation framework, with key operations maintained across Shanghai, Hangzhou, and California.
Rhône has completed acquisitions of Invacare Holdings S.ar.l. (Invacare Europe & APAC) and Direct Healthcare Group (DHG) through vehicles held by its Fund VI and combined the businesses to form DHCare, a London‑headquartered medical device platform. The transaction closed January 30, 2026; ARCHIMED will retain a minority stake in the newly formed company, which expands the combined product portfolio across mobility, seating, pressure‑care, patient handling and rental/services.
Symmetry Laser has completed its acquisition of ArcRev, a specialized laser cutting company with a lean manufacturing culture. The deal expands Symmetry Laser’s technical capabilities and production capacity to better support medical device customers from rapid prototyping through high-volume production.
Drive Medical, a manufacturer and distributor of durable medical equipment and respiratory products, signed a definitive agreement to acquire Compass Health Brands, a diversified supplier of branded and private label consumer medical products (including ProBasics, Carex, and TheraMed). Compass will operate as a division of Drive Medical, with a phased integration following closing. Terms were not disclosed.
Healthcare Holding Schweiz AG has acquired PlusORTHO Prothetik GmbH, an Oftringen-based specialist in orthopedic hand, foot and knee implants, fixation systems and surgical instruments. The bolt-on expands Healthcare Holding Schweiz's Orthopedic Solutions platform to broaden its product portfolio, improve delivery times and deepen clinical/OR support, with PlusORTHO's founder Andreas Keller remaining involved post-transaction.
Laborie Medical Technologies has completed the acquisition of the JADA® System and the team behind it from Organon in a transaction announced in late January 2026. The deal — part of Organon’s divestiture program (previously disclosed as up to $465 million) — brings more than 90 employees and an FDA-cleared device for rapid control of postpartum hemorrhage into Laborie’s obstetrics portfolio to expand the company’s maternal health capabilities.
Aspen Surgical Products has acquired Ruhof Healthcare, a Mineola, New York–based maker of enzymatic detergents, cleaning verification systems, and instrument/endoscope reprocessing solutions. The acquisition (terms not disclosed) brings Ruhof's products and ~ $50M in revenue into Aspen's SPD360 Performance Solutions platform to expand its infection‑prevention, reprocessing, and endoscopy portfolios and accelerate international growth.
Perimeter Solutions, Inc. (NYSE: PRM) completed its acquisition of Medical Manufacturing Technologies LLC (MMT) from Arcline Investment Management for approximately $685 million in cash, including certain tax benefits. The transaction was financed with cash on hand and proceeds from a senior secured notes offering that closed on January 2, 2026.
BioStem Technologies (OTC: BSEM) has acquired the surgical and wound care business of BioTissue Holdings, Inc. for approximately $15 million upfront, with up to $25 million of contingent milestone and royalty payments. The deal includes the Neox and Clarix product lines, a nationwide commercial sales organization and assigned GPO contracts, expanding BioStem's access into hospital inpatient and outpatient wound-care markets and adding assets that generated roughly $29 million in 2025.
Full Export
Get the full acquisitions list for this page as CSV + XLSX.
Find buyers actively acquiring medical devices companies.